ETFs are the best investment idea to come along in the last generation.
Our goal is to provide guidance as to which sectors are going up and which are in decline. We also see a need to differentiate specific funds by their characteristics. We will advise you about strategies that can be used to hedge your risk or enhance your returns.
Each month ETF Investor will provide you with recommendations of funds to buy by sector, for the US and international markets. » More... Click for a FREE TRIAL to ETF Investor »»»
Jack Adamo recommends writing covered call options for safe, high income. Writing options (the opposite of buying them) is a favorite strategy of the super rich to grow their wealth rapidly and safely. In 2004 Jack?s recommendations beat all the major averages with an annualized return of 11.4%. In 2003 his calls returned 27% annualized. In both years his readers took substantially less risk than the market. » More... Click for a FREE TRIAL to Option Income Advisor »»»
Dedicated to the needs of advanced, profit hungry traders. Approximately 15 to 20 recommendations monthly including short-term calls and puts, debit and credit spreads, and LEAPs and covered call combinations. » More... Click for a FREE TRIAL to Ultimate Option Strategies »»»
A SUPER ECONOMIC BOOM IS COMING! Momentum investor, Donald Rowe brings decades of experience and helps you utilize The Wall Street Profit System 2005? to double your money every three years!» More... Click for a FREE TRIAL to The Wall Street Digest »»»
Buyback Premium Portfolio Soars +145.34% since 8/00, outperforming the S&P 500 (as of March 31, 2008) by 153.34%! David Fried is on to something BIG with his Premium Portfolio, a focused 5-stock group for experienced, elite investors. Using his unique high-octane strategy, subscribers can double their money every 1.8 years even in today?s market! Supercharge your portfolio today! » More... Click for a FREE TRIAL to Buyback Premium Portfolio »»»
The Oberweis Report is a proprietary investment advisory letter specializing in stocks of extraordinarily rapidly growing companies. Each issue contains new stock recommendations along with a review of those previously recommended stocks that have yet to be sold. » More... Click for a FREE TRIAL to Oberweis Report »»»
Rated NO. 1 by Hulbert Financial Digest! The Coolcat Explosive Small Cap Growth Stock Report, was established in October 1997 and is ranked America?s No. 1 investment newsletter for seven years from 1999-2005 by The Hulbert Financial Digest with a 429.4% gain (+26.9% annualized). » More... Click for a FREE TRIAL to Coolcat Explosive Small Cap Growth Stock Report »»»
Insiders Plus had a 48% gain in 2007
thrashing all the major averages
JACK ADAMO'S INSIDERS PLUS is a weekly Internet-based newsletter that provides guidance on investment opportunities with superior risk-to-reward probabilities, primarily in three areas:
Insider transactions, "Smart Money" purchases, Special situations.
These three areas are briefly discussed on the following page. » More... Click for a FREE TRIAL to Insiders PLUS »»»
Invest with the confidence of knowing that your decisions have been validated by strategies of Wall Street legends that have proven to outperform the market. The Validea Hot List contains a portfolio of stocks that pass our interpretation of the strategies of the world?s most astute investment minds, including Graham, Lynch, Zweig, Buffett and others. Validea?s extensive research has shown that when these strategies agree, the result is market beating returns and low levels of risk. » More... Click for a FREE TRIAL to The Validea Hot List »»»
Growth Report?s Ian Wyatt is on a mission to discover undervalued high growth investment opportunities by guiding investors through uncertain markets with sensible investment ideas and a proven investment philosophy. Growth Report?s long-term approach to investing in small-cap growth stocks delivered returns of 40% in 2002, and 52% in 2003. Some of Ian's individual stock picks were up 1,091%, 849%, and 357% in 2003. » More... Click for a FREE TRIAL to Growth Report »»»
BioTech Stock Report is an 'information integrator' specializing in biotechnology stocks. We bring together the mass of medical scientific data that is available and interpret it for you. Each report gives a detailed rationale explaining the technology, examining new products, evaluating their potential, the markets and the likely impact it has on a company's future. » More... Click for a FREE TRIAL to BioTech Stock Report »»»
Sponsored Links 
